$2.820
-0.115 (-4.08%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による VRAX の予測・予想
Alphio's VRAX stock price prediction model matches the current Virax Biolabs Group Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.85 (+1.09%). The 1-week path is $3.15 (+11.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Virax Biolabs Group Ltd 株は買うべき？
Currently, Virax Biolabs Group Ltd (VRAX) is not a strong buy due to its significant year-to-date decline of 70.62% and a negative forward P/E ratio of 0, indicating potential challenges in future earnings. The RSI is at 42.168, suggesting the stock is nearing oversold conditions, but the recent 5-day change of -11.60% raises concerns about short-term momentum. The main risk is its low trading volume of 37,110 compared to an average of 1,008,051, indicating a lack of investor interest and liquidity.
VRAX の株価は Friday に $2.82 で引け、その前に下落 -4.08%
Virax Biolabs Group Ltd (VRAX) last closed at $2.82, losing -4.08%. These facts feed the 1-day and 1-week VRAX price prediction above.
予想の要因
Virax Biolabs Group Ltd（VRAX）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが VRAX に最も近い銘柄を、類似度順に表示します。
VRAX の季節性分析
Historically the probability of a positive August return for VRAX is 20.63%. November offers the highest probability of a positive month at 51.28%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。